Alluvi, previously BI 4744, represents a notable development in weight management therapy. This dual stimulator targeting both GLP-1 and GIP targets demonstrates remarkable efficacy in research trials, potentially https://socialevity.com/story24342035/alluvi-a-detailed-dive-into-the-medication-s-potential